EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphoma

American Journal of Clinical Pathology

Volumn 128, Issue 4, 2007, Pages 579-584

  Hsieh, Pin Pen ^a,e   Tung, Chun Liang ^b   Chan, Amy Bik Wan ^c   Liao, Jia Bin ^a   Wang, Jyh Seng ^a   Tseng, Hui Hwa ^a   Su, Hsing Hao ^a   Chang, Kun Chao ^d   Chang, Chung Che ^e,f  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Epstein Barr viral load; Nasal NK T cell lymphoma; Prognostic factor

Indexed keywords

ANTINEOPLASTIC AGENT; CD56 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; ETHMOID SINUS; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MAXILLARY SINUS; NATURAL KILLER T CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LYMPHOMA; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; NOSE NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RNA, VIRAL; SURVIVAL RATE; VIRAL LOAD;

EID: 35348915352     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/MN4Y8HLQWKD9NB5E     Document Type: Article

References (29)

1. Aviles A, Rodriguez L, Guzman R, et al. Angiocentric T-cell lymphoma of the nose, paranasal sinuses and hard palate. Hematol Oncol. 1992;10:141-147.
2. Ferry JA, Sklar J, Zukerberg LR, et al. Nasal lymphoma: a clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol. 1991;15:268-279.
3. Robbins KT, Fuller LM, Vlasak M, et al. Primary lymphomas of the nasal cavity and paranasal sinuses. Cancer. 1985;56:814-819.
4. Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Cancer. 1998;83:806-812.
5. Au WY, Ma SY, Chim CS, et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol. 2005;16:206-214.
6. Chim CS, Ma SY, Au WY, et al. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood. 2004;103:216-221.
7. Kim K, Kim WS, Jung CW, et al. Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American Lymphoma (REAL) classification. Eur J Cancer. 2002;38:75-81.
8. Lee J, Park YH, Kim WS, et al. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer. 2005;41:1402-1408.
9. Kuo TT, Shih LY, Tsang NM. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol. 2004;12:375-387.
10. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology. 2000;36:69-86.
11. Chan JKC, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:204-207. World Health Organization Classification of Tumours.
12. Cheung MM, Chan JK, Lau WH, et al. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys. 2002;54:182-190.
13. Aviles A, Diaz NR, Neri N, et al. Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. Clin Lab Haematol. 2000;22:215-220.
14. You JY, Chi KH, Yang MH, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol. 2004;15:618-625.
15. Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol. 2006;24:612-618.
16. Kim TM, Park YH, Lee SY, et al. Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type. Blood. 2005;106:3785-3790.
17. Siu LL, Chan JK, Kwong YL. Natural killer cell malignancies: clinicopathologic and molecular features. Histol Histopathol. 2002;17:539-554.
18. Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the tole of radiotherapy and chemotherapy. Cancer. 1998;83:449-456.
19. Logsdon MD, Ha CS, Kavadi VS, et al. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer. 1997;80:477-488.
20. Lei KI, Chan LY, Chan WY, et al. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma. Clin Cancer Res. 2002;8:29-34.
21. Jaffe ES, Chan JK, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103-111.
22. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome m 113 patients. J Clin Oncol. 1998;16:70-77.
23. King AD, Lei KI, Ahuja AT, et al. MR imaging of nasal T-cell/natural killer cell lymphoma. AJR Am J Roentgenol. 2000;174:209-211.
24. Koom WS, Chung EJ, Yang WI, et al. Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys. 2004;59:1127-1137.
25. Ryan JL, Fan H, Glaser SL, et al. Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn. 2004;6:378-385.
26. Lei KI, Chan LY, Chan WY, et al. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol. 2000;111:239-246.
27. van Esser JW, Niesters HG, Thijsen SF, et al. Molecular quantification of viral load in plasma allows for fast and accurate ptediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol. 2001;113:814-821.
28. Solassol J, Kreuzer KA, Lass U, et al. Epstein-Barr virus DNA quantitation assessed by a real-time polymerase chain reaction in a case of Burkitt's lymphoma. Leuk Lymphoma. 2001;41:669-673.
29. Ko YH, Ree HJ, Kim WS, et al. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans. Cancer. 2000;89:2106-2116.